Naoya Murakami: Influence Statistics

Naoya Murakami

Naoya Murakami

Department of Radiation Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan | Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan | ...

Naoya Murakami: Expert Impact

Concepts for which Naoya Murakami has direct influence: Cervical cancer , Interstitial brachytherapy , Radiation therapy , Uterine cervical , Stereotactic body radiotherapy , Stereotactic radiosurgery , Definitive radiotherapy .

Naoya Murakami: KOL impact

Concepts related to the work of other authors for which for which Naoya Murakami has influence: Cervical cancer , Radiation therapy , Uveal melanoma , Local control , Hepatocellular carcinoma , Stereotactic radiosurgery , Prone position .

KOL Resume for Naoya Murakami

Year
2022

Department of Radiation Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan

2021

Department of Radiation Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, Japan

2020

Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

2019

Department of Radiation Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

2018

Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 1040045, Japan;,

2017

Department of Radiation oncology, National Cancer Center Hospital, Tokyo.

2016

Department of Radiation Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo

2015

Department of Radiology, National Cancer Center Hospital

2014

Department of Radiation Oncology, National Cancer Center Hospital, 104-0045, Tokyo, Japan.

2013

Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan

2012

Division of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan

2009

Department of Radiology, The University of Tokyo Hospital

2008

Department of Radiology, University of Tokyo Hospital, Tokyo, Japan

Prominent publications by Naoya Murakami

KOL-Index: 11580 . BACKGROUND AND AIMS: Stereotactic body radiotherapy (SBRT) is a relatively new treatment for liver tumor. The outcomes of SBRT for liver tumor unfit for ablation and surgical resection were evaluated. METHODS: Liver tumor patients treated with SBRT in seven Japanese institutions were studied retrospectively. Patients given SBRT for liver tumor between 2004 and 2012 were collected. Patients ...
Known for Stereotactic Body Radiotherapy | Liver Tumor | Patients Sbrt | Local Control
KOL-Index: 9216 . Stereotactic body radiotherapy (SBRT) is widely used as a curative treatment option for stage I non-small-cell lung cancer, but for patients with stage I small-cell lung cancer, the role of stereotactic body radiotherapy is unclear. In this study, we retrospectively analyzed the outcomes of a subset of patients with stage I small-cell lung cancer treated with stereotactic body radiotherapy ...
Known for Stereotactic Body Radiotherapy | Cell Lung | Stage Small | Prophylactic Cranial Irradiation
KOL-Index: 9079 . BACKGROUND: The major stress-inducible heat shock protein 70 (Hsp70) is frequently overexpressed in the cytosol and integrated in the plasma membrane of tumor cells via lipid anchorage. Following stress such as non-lethal irradiation Hsp70 synthesis is up-regulated. Intracellular located Hsp70 is known to exert cytoprotective properties, however, less is known about membrane (m)Hsp70. ...
Known for Tumor Cells | Membrane Hsp70 | Hsf1 Kd | Clonogenic Cell Survival
KOL-Index: 8622 . PURPOSE: To evaluate the natural history, behavior of progression, prognostic factors, and treatment-related adverse effects of primary ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML). METHODS AND MATERIALS: Eighty-six patients with histologically proven stage I POAML treated with radiation therapy at National Cancer Center Hospital, Tokyo between 1990 and 2010 ...
Known for Radiation Therapy | Adnexal Mucosa | Lymphoma Treated | Patients Poaml
KOL-Index: 8373 . Purpose Concurrent administration of Cetuximab with radiotherapy (Cetuximab-radiation) has been accepted as an alternative option for locally advanced head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to retrospectively compare complications of Cetuximab-radiation with those of concurrent chemoradiation (cCRT) with a special concern on gastrointestinal (GI) ...
Known for Locally Advanced Head | Squamous Cell | Gastrointestinal Bleeding | Patients Cetuximab
KOL-Index: 8306 . BACKGROUND: The favorable response rate of radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication has been demonstrated. However, there are limited data available on the long-term outcomes. The aim of this retrospective study was to evaluate the long-term outcomes of radiotherapy for localized gastric mucosa-associated ...
Known for Gastric Mucosa | Tissue Lymphoma | Helicobacter Pylori | Longterm Outcomes
KOL-Index: 8234 . During radiotherapy for gastric lymphoma, it is difficult to protect the liver and kidneys in cases where there is considerable overlap between these organs and the target volume. This study was conducted to compare the three radiotherapy planning techniques of four-fields 3D conformal radiotherapy (3DCRT), half-field radiotherapy (the half-beam method) and intensity-modulated radiotherapy ...
Known for Gastric Lymphoma | 3dcrt Imrt | Modulated Radiotherapy | Liver Kidneys
KOL-Index: 8007 . PURPOSE: The expressions of six cell-cycle-associated proteins were analyzed in cervical squamous cell carcinomas in correlation in a search for prognostic correlations in tumors treated with concurrent chemoradiation therapy (cCRT). METHODS AND MATERIALS: The expressions of p53, p21/waf1/cip1, molecular immunology borstel-1 (MIB-1), epidermal growth factor receptor (EGFR), human epidermal ...
Known for Cell Cervical | Receptor Egfr | Carcinoma Squamous | P53 Uterine
KOL-Index: 7896 . BACKGROUND: Purpose of this study was to identify predictors of vaginal ulcer after CT based three-dimensional image-guided high-dose-rate interstitial brachytherapy (HDR-ISBT) for gynecologic malignancies. METHODS: Records were reviewed for 44 female (14 with primary disease and 30 with recurrence) with gynecological malignancies treated with HDR-ISBT with or without external beam ...
Known for Gynecological Malignancies | Dose Rate | Vaginal Wall | Image Guided
KOL-Index: 7875 . Stereotactic radiosurgery is now a treatment option for meningiomas, especially for high-risk patients such as those with skull base lesions. The clinical outcomes were retrospectively analyzed of stereotactic radiosurgery using the Leksell Gamma Knife((R)) performed for 98 patients with 106 skull base meningiomas at the University of Tokyo Hospital between June 1990 and April 2006 and ...
Known for Stereotactic Radiosurgery | Skull Base | 5 Years | Local Control
KOL-Index: 7799 . OBJECTIVES/HYPOTHESIS: Treatment of head and neck squamous cell carcinoma (HNSCC) often requires radiotherapy, but relapse can occur. There is, therefore, an urgent need for the identification of a predictive novel biomarker for radiosensitivity. The epithelial cell adhesion molecule (EpCAM) has been shown to promote the transformation of malignant tumors, and EpCAM may have prognostic ...
Known for Glottic Cancer | Epcam Expression | Hnscc Patients | Cell Adhesion
KOL-Index: 7654 . BACKGROUND: In this study, high risk clinical target volumes (HR-CTVs) according to GEC-ESTRO guideline were contoured retrospectively based on CT images taken at the time of high-dose rate intracavitary brachytherapy (HDR-ICBT) and correlation between clinical outcome and dose of HR-CTV were analyzed. METHODS: Our study population consists of 51 patients with cervical cancer (Stages ...
Known for Cervical Cancer | Dose Rate | Intracavitary Brachytherapy | Weekly Cisplatin
KOL-Index: 7578 . Stereotactic body radiotherapy (SBRT) is a relatively new treatment for liver tumor. Outcomes of SBRT for liver tumors unsuitable for ablation or surgical resection were evaluated. A total of 79 patients treated with SBRT for primary hepatocellular carcinoma (HCC) between 2004 and 2012 in six Japanese institutions were studied retrospectively. Patients treated with SBRT preceded by ...
Known for Stereotactic Body Radiotherapy | Hepatocellular Carcinoma | Hcc Patients | Liver Tumors
KOL-Index: 7308 . BACKGROUND: There is no consensus on the indication for salvage chemoradiotherapy (CRT) after failure of primary chemotherapy for locally advanced pancreatic cancer (LAPC). Here we report on the retrospective analysis of patients who received salvage CRT after primary chemotherapy for LAPC. The primary objective of this study was to evaluate the efficacy and safety of salvage CRT after ...
Known for Patients Lapc | Pancreatic Cancer | Chemoradiotherapy Crt | Neoplasms Prognosis
KOL-Index: 7078 . BACKGROUND: This prospective study aimed to compare dose volume histograms (DVH) of the breasts and organs at risk (OARs) of whole breast radiotherapy in the supine and prone positions, and frequency and severity of acute and late toxicities were analyzed. METHODS: Early-stage breast cancer patients with large breasts (Japanese bra size C or larger, or the widest measurements of the ...
Known for Prone Position | Breast Radiotherapy | Dosimetric Parameters | Treatment Plans

Key People For Cervical Cancer

Top KOLs in the world
#1
Freddie Ian Bray
cancer incidence nordic countries mortality rates
#2
Jacques Ferlay
cancer incidence global burden latin america
#3
Chris J L M Meijer
cervical cancer human papillomavirus hpv dna
#4
Ahmedin M Jemal
united states breast cancer addis ababa
#5
Nubia Muñoz
cervical cancer human papillomavirus hpv dna
#6
Sı´lvia de Sanjosé
cervical cancer human papillomavirus hpv dna

Department of Radiation Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan | Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan | Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsuk